Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Distinct epidemiologic patterns of mesothelioma: evidence from a 16-year provincial cohort in China.

BMC cancer·2026
Same author

Safety of fruquintinib mono- and combo therapy in metastatic colorectal cancer: real-world subgroup analysis from China.

Future oncology (London, England)·2026
Same author

IL-17 promotes H1299 cell proliferation via LINC01518/miR-20a-5p/E2F1 axis in non-small cell lung cancer.

Neoplasma·2026
Same author

Rezivertinib in <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study.

Cancer communications (London, England)·2026
Same author

Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.

EMBO molecular medicine·2026
Same author

Deficiencies in germline DNA repair are associated with early-onset gastrointestinal cancers and inform precision prevention strategies.

Journal of translational medicine·2025

相关实验视频

Updated: Jan 14, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.1K

基于机器学习的胃癌预测模型使用集成的多omics数据.

Minyue Shou1, Yuqing Liu1, Yongqian Shu1

  • 1Department of Oncology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.

Cancer investigation
|October 20, 2025
PubMed
概括
此摘要是机器生成的。

这项研究整合了多学科数据,以创建胃癌 (GC) 的新预后框架. 该框架改善了患者风险分层,并确定了精准医学的潜在治疗目标.

关键词:
胃癌 胃癌是指胃癌.基因表达 基因表达 基因表达甲基化 甲基化 甲基化分子子类型 分子子类型多领域的整合.预测生物标志物 预测生物标志物

更多相关视频

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.2K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.5K

相关实验视频

Last Updated: Jan 14, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.1K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.2K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.5K

科学领域:

  • 基因组学和生物信息学
  • 癌症研究 癌症研究
  • 分子瘤学分子瘤学

背景情况:

  • 目前的方法对胃癌 (GC) 的预后定义不佳.
  • 分子异质性需要先进的方法来准确预测.

研究的目的:

  • 开发一个强大的多omics预后框架,用于胃癌.
  • 确定分子亚型和预后特征,以改善患者分层和向治疗.

主要方法:

  • 对108名GC患者的转录组,表观组和临床数据的协同分析.
  • 全基因组表达特征分析,甲基化阵列分析和相似性网络融合.
  • 开发一个LASSO衍生的预后签名和一个多omics nomogram.

主要成果:

  • 确定了1,243个与生存相关的转录和8,742个预后CpG位点.
  • 揭示了具有明显临床结果的三种分子亚型;亚型3显示死亡风险明显更高.
  • 多omics签名实现了卓越的预后歧视 (C指数:0.786) 和超越现有系统.

结论:

  • 与传统方法相比,多omics集成为胃癌提供了更高的预后精细化.
  • 确定了特定亚型的途径 (细胞循环,免疫逃避) 和潜在的治疗点 (CDK/PI3K 抑制剂).
  • 这一框架为改善胃癌管理提供了精确治疗指导.